STAAR Surgical Generates $464,000 in Cash from Operations During Thi...(-------- --------- ----------- ----...),Health

Date:11/2/2009

-------- --------- ----------- --------- US 12,329 - 12,329 14,468 International 43,185 (1,270) 44,455 42,269 ------ ------ ------ ------ Total 55,514 (1,270) 56,784 56,737 ====== ====== ====== ====== Q3 2009 vs. Q3 2008 ------------------- As Reported Ex-Currency ----------- ----------- Sales in Constant Currency $ Change % Change $ Change % Change -------- -------- -------- -------- US (729) -15% (729) -15% International 730 5% 676 5% Total 1 0% (53) 0% As Reported Ex-Currency ----------- ----------- Sales in Constant Currency $ Change % Change $ Change % Change -------- -------- -------- -------- US (2,139) -15% (2,139) -15% International 916 2% 2,186 5% Total (1,223) -2% 47 0% Nine Months % of October 2, % of Statement of Operations Sales 2009 Sales ----- ---- ----- Net sales 100% $55,514 100% Cost of sales 44% 24,675 48% ------ Gross profit
'/>"/>

SOURCE STAAR Surgical Company Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Related medicine technology :

1. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
2. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
6. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
7. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
10. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery